These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38222314)

  • 21. Impact of mature tertiary lymphoid structures on prognosis and therapeutic response of Epstein-Barr virus-associated gastric cancer patients.
    Yin YX; Ling YH; Wei XL; He CY; Wang BZ; Hu CF; Lin WP; Nie RC; Chen JW; Lin JL; Zhou J; Xie JJ; Yun JP; Xie D; Xue LY; Cai MY
    Front Immunol; 2022; 13():973085. PubMed ID: 36591236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.
    Langouo Fontsa M; Padonou F; Willard-Gallo K
    Expert Rev Clin Immunol; 2024 Aug; 20(8):839-847. PubMed ID: 39007892
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of peritumoral tertiary lymphoid structures in breast cancer.
    Sofopoulos M; Fortis SP; Vaxevanis CK; Sotiriadou NN; Arnogiannaki N; Ardavanis A; Vlachodimitropoulos D; Perez SA; Baxevanis CN
    Cancer Immunol Immunother; 2019 Nov; 68(11):1733-1745. PubMed ID: 31598757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of immune cell infiltration, tertiary lymphoid structures and PD-L1 expression in Merkel cell carcinomas.
    Behr DS; Peitsch WK; Hametner C; Lasitschka F; Houben R; Schönhaar K; Michel J; Dollt C; Goebeler M; Marx A; Goerdt S; Schmieder A
    Int J Clin Exp Pathol; 2014; 7(11):7610-21. PubMed ID: 25550797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade.
    Shu DH; Ho WJ; Kagohara LT; Girgis A; Shin SM; Danilova L; Lee JW; Sidiropoulos DN; Mitchell S; Munjal K; Howe K; Bendinelli KJ; Qi H; Mo G; Montagne J; Leatherman JM; Lopez-Vidal TY; Zhu Q; Huff AL; Yuan X; Hernandez A; Coyne EM; Zaidi N; Zabransky DJ; Engle LL; Ogurtsova A; Baretti M; Laheru D; Durham JN; Wang H; Anders R; Jaffee EM; Fertig EJ; Yarchoan M
    bioRxiv; 2023 Oct; ():. PubMed ID: 37904980
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Germinal center reactions in tertiary lymphoid structures associate with neoantigen burden, humoral immunity and long-term survivorship in pancreatic cancer.
    J Gunderson A; Rajamanickam V; Bui C; Bernard B; Pucilowska J; Ballesteros-Merino C; Schmidt M; McCarty K; Philips M; Piening B; Dubay C; Medler T; Newell P; Hansen P; Tran E; Tang E; Bifulco C; Crittenden M; Gough M; Young KH
    Oncoimmunology; 2021 Mar; 10(1):1900635. PubMed ID: 33796412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular, Immunological, and Clinical Features Associated With Lymphoid Neogenesis in Muscle Invasive Bladder Cancer.
    Pagliarulo F; Cheng PF; Brugger L; van Dijk N; van den Heijden M; Levesque MP; Silina K; van den Broek M
    Front Immunol; 2021; 12():793992. PubMed ID: 35145509
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor microenvironment-based signatures distinguish intratumoral heterogeneity, prognosis, and immunogenomic features of clear cell renal cell carcinoma.
    Anwaier A; Xu W; Liu W; Wei S; Tian X; Qu Y; Yang J; Zhang H; Ye D
    J Natl Cancer Cent; 2023 Sep; 3(3):236-249. PubMed ID: 39035192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral tertiary lymphoid structures promote patient survival and immunotherapy response in head neck squamous cell carcinoma.
    Liu Z; Meng X; Tang X; Zou W; He Y
    Cancer Immunol Immunother; 2023 Jun; 72(6):1505-1521. PubMed ID: 36481914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tertiary lymphoid structure patterns aid in identification of tumor microenvironment infiltration and selection of therapeutic agents in bladder cancer.
    An Y; Sun JX; Xu MY; Xu JZ; Ma SY; Liu CQ; Liu Z; Wang SG; Xia QD
    Front Immunol; 2022; 13():1049884. PubMed ID: 36420257
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Existence of intratumoral tertiary lymphoid structures is associated with immune cells infiltration and predicts better prognosis in early-stage hepatocellular carcinoma.
    Li H; Wang J; Liu H; Lan T; Xu L; Wang G; Yuan K; Wu H
    Aging (Albany NY); 2020 Feb; 12(4):3451-3472. PubMed ID: 32087064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer.
    Giraldo NA; Becht E; Pagès F; Skliris G; Verkarre V; Vano Y; Mejean A; Saint-Aubert N; Lacroix L; Natario I; Lupo A; Alifano M; Damotte D; Cazes A; Triebel F; Freeman GJ; Dieu-Nosjean MC; Oudard S; Fridman WH; Sautès-Fridman C
    Clin Cancer Res; 2015 Jul; 21(13):3031-40. PubMed ID: 25688160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tertiary Lymphoid Structure-Associated B Cells Enhance CXCL13
    Hu C; You W; Kong D; Huang Y; Lu J; Zhao M; Jin Y; Peng R; Hua D; Kuang DM; Chen Y
    Gastroenterology; 2024 Jun; 166(6):1069-1084. PubMed ID: 38445519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Density of tertiary lymphoid structures and their correlation with prognosis in non-small cell lung cancer.
    Xin S; Wen S; He P; Zhao Y; Zhao H
    Front Immunol; 2024; 15():1423775. PubMed ID: 39192984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of programmed death ligand 1 (PD-L1) and the immune microenvironment in laryngeal carcinoma.
    Alessandrini L; Franz L; Ottaviano G; Ghi MG; Lanza C; Blandamura S; Marioni G
    Oral Oncol; 2020 Sep; 108():104836. PubMed ID: 32512470
    [TBL] [Abstract][Full Text] [Related]  

  • 38. m
    Xu W; Tian X; Liu W; Anwaier A; Su J; Zhu W; Wan F; Shi G; Wei G; Qu Y; Zhang H; Ye D
    Front Oncol; 2021; 11():709579. PubMed ID: 34295828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The enrichment of the gut microbiota Lachnoclostridium is associated with the presence of intratumoral tertiary lymphoid structures in hepatocellular carcinoma.
    Zhao R; Li J; Chen B; Zhao J; Hu L; Huang K; Chen Q; Yao J; Lin G; Bao L; Lu M; Wang Y; Chen G; Wu F
    Front Immunol; 2023; 14():1289753. PubMed ID: 38116013
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spatial dynamics of tertiary lymphoid aggregates in head and neck cancer: insights into immunotherapy response.
    Sadeghirad H; Monkman J; Tan CW; Liu N; Yunis J; Donovan ML; Moradi A; Jhaveri N; Perry C; Adams MN; O'Byrne K; Warkiani ME; Ladwa R; Hughes BGM; Kulasinghe A
    J Transl Med; 2024 Jul; 22(1):677. PubMed ID: 39049036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.